Benign prostatic hyperplasia: variability in practice and guide to action based on scientific evidence
Baile, A.; Asua, J.; Albisu, A.
Atencion Primaria 23(3): 142-150
1999
ISSN/ISBN: 0212-6567 PMID: 10095285 Document Number: 508173
Document emailed within 1 workday
Related Documents
Schnur, S.; Keuler, F.U. 1996: Benign prostatic hyperplasia: diagnosis in general practice Fortschritte der Medizin 114(31): 412-415Jonas, U.; Melchior, H.; Rübben, H. 1998: Recommendations for billing alternative therapy of benign prostatic hyperplasia. Laser therapy of benign prostatic hyperplasia Der Urologe. Ausg. a 37(1): 110-111
Eri, L.M.; Wahlqvist, R.; Tveter, K.J. 1996: Diagnosis and treatment of benign prostatic hyperplasia in general practice. Norwegian Medical Society Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 116(27): 3240-3244
Lukacs, B.; Grange, J.C.; Comet, D.; Mc Carthy, C. 1999: Prospective follow-up of 3,228 patients suffering from clinical benign prostatic hyperplasia (BPH) treated for 3 years wi alfuzosin in general practice. BPH Group in General Practice Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 9(2): 271-280
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Franco, G. 2001: From scientific evidence to operative practice: towards a model of occupational medicine based on on efficacy evidence La Medicina del Lavoro 92(3): 159-165
Brannen, G.E.; Coffey, D.S. 1977: Tumor-specific immunity in patients with prostatic adenocarcinoma or benign prostatic hyperplasia Cancer Treatment Reports 61(2): 211-216
Kletscher, B.A.; Oesterling, J.E. 1995: Prostatic stents. Current perspectives for the management of benign prostatic hyperplasia Urologic Clinics of North America 22(2): 423-430
Gu, F. 2000: Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China Chinese Medical Journal 113(4): 299-302
Blanc, M.; Sacrini, A.; Avogadro, A.; Gattamorta, M.; Lazzerini, F.; Gattoni, F.; Cretti, F. 1998: Prostatic volume: suprapubic versus transrectal ultrasonography in the control of benign prostatic hyperplasia La Radiologia Medica 95(3): 182-187
Pretlow, T.G.; Whitehurst, G.B.; Pretlow, T.P.; Hunt, R.S.; Jacobs, J.M.; McKenzie, D.R.; McDaniel, H.G.; Hall, L.M.; Bradley, E.L. 1982: Decrease in creatine kinase in human prostatic carcinoma compared to benign prostatic hyperplasia Cancer Research 42(11): 4842-4848
Abdul-Muhsin, H.M.; Jakob, N.J.; McLemore, R.M.; McAdams, S.B.; Humphreys, M.R. 2016: Infectious complications associated with the use of temporary prostatic urethral stents in patients with benign prostatic hyperplasia Canadian Journal of Urology 23(5): 8465-8470
Granados Loarca, E.A. 1999: Medical treatment of benign prostatic hyperplasia. The efficacy of finasteride depends on prostatic volume Archivos Espanoles de Urologia 52(3): 201-208
Tickle-Degnen, L. 2001: Choosing books to guide evidence-based practice American Journal of Occupational Therapy: Official Publication of the American Occupational Therapy Association 55(1): 109-110
Maygarden, S.J.; Strom, S.; Ware, J.L. 1992: Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia Archives of Pathology and Laboratory Medicine 116(3): 269-273
Schönberger, B. 1986: Benign prostatic hyperplasia Zentralblatt für Chirurgie 111(10): 569-588
Kumah, E.A.; McSherry, R.; Bettany-Saltikov, J.; van Schaik, P.; Hamilton, S.; Hogg, J.; Whittaker, V. 2022: Evidence-informed practice versus evidence-based practice educational interventions for improving knowledge, attitudes, understanding, and behavior toward the application of evidence into practice: a comprehensive systematic review of UG student Campbell Systematic Reviews 18(2): E1233
Hiraoka, Y.; Sa, I. 2002: Biochemical diagnosis of benign prostatic hyperplasia (including differential diagnosis with prostatic carcinoma) Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 11): 342-345
Concato, J.; Horwitz, R.I.; Feinstein, A.R.; Elmore, J.G.; Schiff, S.F. 1993: Therapies for benign prostatic hyperplasia JAMA 269(7): 867
Thomas, D. 1997: When to investigate benign prostatic hyperplasia Practitioner 241(1576): 408-413